Search:
Pharmaceutical Contract Manufacturing Company
 

 
 
Peptide Synthesis Filling Machine
Aseptic Fill of Custom Peptide
 
 

Custom Peptide Synthesis

Our GMP Custom Peptide Synthesis laboratory is equipped with state of the art equipment for the mass production, purification, Aseptic fill finish and QC of synthetic peptides. Our peptide service includes the manufacture of normal peptides and custom modified peptides to suit your requirements. Our expertise with synthetic and analytical chemistry is used in this important service to the research community to help with your drug discovery and drug development processes. We have the capacity for aseptic filling up to 1,800 vials of lyophilized peptides.

Dalton is a full service peptide company. Solid phase peptide synthesis or solution phase chemistry is used to manufacture your custom peptides. Pre or post synthesis operations and the chemistry itself can incorporate natural amino acids, modified amino acids, and unnatural amino acids. Post synthesis modifications include biotinylation, peptide conjugation, KLH conjugation, linker attachment, and more.


We use preparative HPLC to purify the desired peak, and the final compound is analyzed again by reverse phase HPLC to verify purity. Depending on your research needs, Dalton guarantees four levels of purity: crude, >70%, >80% and >95%. Mass spectrometry is used to verify the mass of the peptide.
 

Purification can be rapidly completed with our range of HPLC systems with a 200ml/min flow rate. We have HPLC columns with capacities up to 2.2 litres. Should your Custom Peptide Synthesis requirements be greater, please contact us.
 

We are a peptide company that stand by our products, which are manufactured to the highest quality standards. Learn more about our Custom Drug Synthesis products.
 

If what you are looking for is not on the list please contact us at 1-800-567-5060 or 416-661-2102 or email us and we will gladly meet your GMP Custom Peptide Synthesis needs. We look forward to discussing your requirements for synthetic peptides.